Galderma Group AG (XSWX:GALD) Other Current Payables: CHF74 Mil (As of Dec. 2025)


XSWX:GALD Galderma Group AG XSWX:GALD
15 GF Score
Price CHF180.30
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG Other Current Payables?

Galderma Group AG XSWX:GALD +0.81% 15 Other Current Payables is CHF74 Mil as of Dec. 2025. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

Galderma Group AG's Other Current Payables for the quarter that ended in Dec. 2025 was CHF74 Mil.

Galderma Group AG's quarterly Other Current Payables declined from Dec. 2024 (CHF55 Mil) to Jun. 2025 (CHF0 Mil) but then increased from Jun. 2025 (CHF0 Mil) to Dec. 2025 (CHF74 Mil).

Galderma Group AG's annual Other Current Payables increased from Dec. 2023 (CHF51 Mil) to Dec. 2024 (CHF55 Mil) and increased from Dec. 2024 (CHF55 Mil) to Dec. 2025 (CHF74 Mil).

Galderma Group AG Other Current Payables Related Terms

Galderma Group AG Other Current Payables Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Other Current Payables Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
0.00 0.00 51.02 55.28 74.11

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial 51.02 0.00 55.28 0.00 74.11
XSWX:GALD
15GF Score
Galderma Group AG XSWX:GALD
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of CHF74 Mil mean?
Galderma Group AG (XSWX:GALD) has a Other Current Payables of CHF74 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Galderma Group AG and its competitors.
Is Galderma Group AG's Other Current Payables too high?
Galderma Group AG's current Other Current Payables is CHF74 Mil. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Other Current Payables compare to ZTS and UTHR?
Galderma Group AG's Other Current Payables of CHF74 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Other Current Payables is CHF74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Other Current Payables of CHF74 Mil. The current Other Current Payables is CHF74 Mil. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Other Current Payables is CHF74 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score

Get the complete analysis for XSWX:GALD

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF180.30
Price